Work

The effects of a synbiotic in infants with atopic dermatitis

Year: 2010
Type: other
Abstract: Adapted from: Probiotics and prebiotics in atopic dermatitis: review of the theoretical background and clinical evidence Chapter 1 15 General introduction and Outline of the thesis increase in the prevalence of Th1-mediated autoimmune diseases in the Western world does not concur with the Th1/Th2 paradigm.These inconsistencies have lead to the proposal of a revised hygiene hypothesis, which considers changes in the intestinal colonisation pattern during infancy, also caused by an overly hygienic lifestyle, as an important reason for the increased allergy prevalence and proposes a lack of activity of regulatory T cells (Tregs), causing overactive Th2 as well as Th1 responses, as the underlying mechanism (18)(19)(20)(21). The intestinal microbiotaThe human intestines are inhabited by at least 400 different bacterial species, with the greatest density in the large intestine, where concentrations of 10 11 -10 12 cells/g of luminal contents can be found ( 22).Approximately 55% of faecal mass consists of bacteria (23).After birth, bacteria originating from the mother and the environment start colonizing the infant gut.Factors influencing the colonization pattern are mode of delivery (vaginal delivery versus caesarean section), prematurity, hospitalization or antibiotic use after birth, type of feeding (breastfeeding versus formula feeding) and exposure to older siblings (24).Although some intestinal bacteria are potential pathogens, the relation between the intestinal microbiota and the human host is mostly symbiotic.The microbiota has several important nutritional functions, such as degradation of indigestible dietary carbohydrates, production of short chain fatty acids (SCFA), amino acid synthesis and vitamin synthesis (25).In addition, the intestinal flora appears to be crucial for the development of the mucosal and systemic immune system. The intestinal microbiota and the immune systemThe largest mass of lymphoid tissue of the body is found in the gastrointestinal tract and is called the gut-associated lymphoid tissue (GALT).The GALT interacts with intestinal bacteria, which are sampled by dendritic cells and intestinal epithelial cells, through two classes of pattern recognition receptors, Toll-like receptors (TLR) and nucleotide-binding oligomerization domain (NOD) molecules (26;27).The intestinal microbiota appears to be important for the development of the GALT.Studies have shown that mice without microbiota, i.e. germ-free mice, have an underdeveloped GALT with low numbers of abintestinal intraepithelial lymphocytes (28), hypoplastic Peyer's patches containing few germinal centres and greatly reduced numbers of IgA-producing plasma cells and lamina propria CD4+ T cells (29).Furthermore, the intestinal microbiota also seems to be involved in oral tolerance induction.Oral tolerance is the establishment of peripheral tolerance to a specific antigen after ingestion of that antigen.A pivotal role in the induction and maintenance of peripheral tolerance is played by Tregs.The importance of the intestinal microbiota in tolerance induction was demonstrated by Sudo and coworkers, who showed that germ-free mice do not develop oral tolerance after ingestion of ovalbumin and maintain a Th2 response with IgE production (30).Inoculation with Chapter 1 17 General introduction and Outline of the thesis of bifidobacteria.Recently, a Dutch multicenter trial reported an increased mortality risk in adults with severe acute pancreatitis who received probiotic prophylaxis (44).However, in children with AD no adverse events are reported. Immunomodulatory effects of probioticsMany different effects of probiotics have been described in animal, human and in vitro studies, most of which are strain-specific.In general, effects include stabilizing of intestinal barrier function (45;46), stimulation of intestinal IgA-production (47) and, most importantly, modulation of cytokine production.In vitro studies show that probiotics are able to down-regulate Th2 cytokine production by stimulation of Th1 cytokines, such as IL-12 and IFN-g (48) or regulatory cytokines, such as IL-10.The latter is accomplished by either increasing production of these cytokines by antigen presenting cells or by driving the development of IL-10 or TGF-b producing regulatory T cells (49-51).However, ex vivo immunomodulatory effects of probiotics in children with AD are inconclusive (table 1).There are studies that show up-regulation of IL-10 (52-54) or IFN-g (55;56), although often without accompanying down-regulation of Th2 cytokines, but several studies do not show any effect on cytokine production (57-62).Also, one study showed down regulation of the Th2 cytokine IL-5, combined with down-regulation of IL-10 and TGF-b instead of the expected upregulation of these cytokines (59).These conflicting outcomes could be caused by the use of different probiotic strains and different ways of stimulating cytokine production. PrebioticsPrebiotics are nondigestible food ingredients that beneficially affect the host by stimulating the growth and/or activity of a limited number of bacterial species in the colon (63).A food ingredient must fulfil three criteria to be considered a prebiotic: it should not be hydrolyzed or absorbed in the upper part of the gastrointestinal tract, it has to be a selective substrate for beneficial commensal bacteria in the colon, for example bifidobacteria, and it must be able to alter the intestinal microbiota towards a healthier composition (64).Breast milk contains natural prebiotics, human milk oligosaccharides, which could explain the bifidobacteria-dominated microbiota seen in breast fed infants (65).In formula fed infants a similar effect can be realized with a prebiotic mixture of 90% galacto-oligosaccharides (GOS) and 10% fructo-oligosaccharides (FOS), which stimulates the growth of bifidobacteria (66;67) and, to a lesser extent, lactobacilli (68).Prebiotics are generally considered to be safe, as they are naturally present in several kinds of food.The main side effects of over-consumption in humans are flatulence, bloating and diarrhoea (69).Increased intestinal tumour formation in mice fed inulin has been reported (70), but on the opposite, reduction of colon tumours in mice, has also been described (71).39 Effect of a new synbiotic mixture on atopic dermatitis in infants: a randomized controlled trial ABSTRACT Background: Clinical trials investigating the therapeutic effect of probiotics on atopic dermatitis (AD) show inconsistent results.Better results can possibly be achieved by combining probiotics with prebiotics, i.e. synbiotics.Objective: To investigate the therapeutic effect of a synbiotic mixture on the severity of AD in infants.Methods: In a double-blind, placebo-controlled multicenter trial, ninety infants with AD (SCORAD score ≥ 15), aged < 7 months and exclusively formula fed, were randomly assigned to receive either an extensively hydrolyzed formula with Bifidobacterium breve M-16V and a galacto-/ fructooligosaccharide mixture (Immunofortis®), or the same formula without synbiotics during 12 weeks.The primary outcome was severity of AD, assessed with the SCORAD index.A secondary outcome measure was intestinal microbiota composition.Results: There was no difference in SCORAD score improvement between the synbiotic and the placebo group.The synbiotic group did have a significantly higher percentage of bifidobacteria (54.7% vs. 30.1%,P<0.001) and significantly lower percentages of Clostridium lituseburense/ Clostridium histolyticum (0.5 vs. 1.8,P = 0.02) and Eubacterium rectale/Clostridium coccoides (7.5 vs. 38.1,P < 0.001) after intervention than the placebo group.In the subgroup of infants with IgEassociated AD (n=48), SCORAD score improvement was significantly greater in the synbiotic than in the placebo group at week 12 (-18.1 versus -13.5 points, P = 0.04).Conclusions: This synbiotic mixture does not have a beneficial effect on AD severity in infants, although it does successfully modulate their intestinal microbiota.Further randomized controlled trials should explore a possible beneficial effect in IgE-associated AD.Chapter 5 89 Synbiotics prevent asthma-like symptoms in infants with atopic dermatitis ABSTRACT Background: Infants with atopic dermatitis have a high risk of developing asthma.We investigated the effect of early intervention with synbiotics, a combination of probiotics and prebiotics, on the prevalence of asthma-like symptoms in infants with atopic dermatitis.Methods: In a double-blind, placebo-controlled multicentre trial, ninety infants with atopic dermatitis, age < 7 months, were randomized to receive an extensively hydrolyzed formula with Bifidobacterium breve M-16V and a galacto/fructooligosaccharide mixture (Immunofortis®), or the same formula without synbiotics during 12 weeks.After one year, the prevalence of respiratory symptoms and asthma medication use was evaluated, using a validated questionnaire.Also, total serum IgE and specific IgE against aeroallergens were determined.Findings: Seventy-five children (70.7% male, mean age 17.3 months) completed the one-year follow-up evaluation.The prevalence of 'frequent wheezing' and 'wheezing and/or noisy breathing apart from colds' was significantly lower in the synbiotic than in the placebo group (13.9% vs. 34.2%,ARR -20.3%, 95% CI -39.2% to -1.5%, and 2.8% vs. 30.8%,ARR -28.0%, 95% CI -43.3% to -12.5%, respectively).Significantly less children in the synbiotic than in the placebo group had started to use asthma medication after baseline (5,6% vs. 25,6%, ARR -20.1%, 95% CI -35.7% to -4.5%).Total IgE levels did not differ between the two groups.No children in the synbiotic and 5 children (15.2%) in the placebo group developed elevated IgE levels against cat (ARR -15.2%, 95% CI -27.4% to -2.9%). Conclusion:These results suggest that this synbiotic mixture prevents asthma-like symptoms in infants with atopic dermatitis.
Language: English
Subfield: Food Science
Open Access status: green
OpenAlex ID: W2290113160
Cites: 187
Cited by:
Related to: 10